Why This Overlooked Seattle Drugmaker Could be the Best Biotech Buy Right Now Post author:Sam Post published:November 28, 2017 Post category:BioPharma Omeros is getting a lot of love from investors and analysts these days. Source: BioSpace You Might Also Like Fully Loaded With Nearly 500 Employees in Rockville, GlaxoSmithKline Chief Lays Out 2018 Goals December 7, 2017 Prolacta Bioscience Names New Members And Expands Resources For Dietitians And Clinicians March 30, 2017 Drumroll… New Company Launched August 8, 2017
Fully Loaded With Nearly 500 Employees in Rockville, GlaxoSmithKline Chief Lays Out 2018 Goals December 7, 2017
Prolacta Bioscience Names New Members And Expands Resources For Dietitians And Clinicians March 30, 2017
